Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Alcoholic liver disease.

Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H.

Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7. Review. Erratum in: Nat Rev Dis Primers. 2018 Aug 28;4(1):18.

PMID:
30115921
2.

Fibrogenesis in alcoholic liver disease.

Fujii H, Kawada N.

World J Gastroenterol. 2014 Jul 7;20(25):8048-54. doi: 10.3748/wjg.v20.i25.8048. Review.

3.

Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.

Neuman MG, French SW, Zakhari S, Malnick S, Seitz HK, Cohen LB, Salaspuro M, Voinea-Griffin A, Barasch A, Kirpich IA, Thomes PG, Schrum LW, Donohue TM Jr, Kharbanda KK, Cruz M, Opris M.

Exp Mol Pathol. 2017 Feb;102(1):162-180. doi: 10.1016/j.yexmp.2017.01.003. Epub 2017 Jan 7. Review.

PMID:
28077318
4.

Alcoholic and non-alcoholic steatohepatitis.

Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A, Thompson KJ, McKillop IH, Kirpich IA, McClain CJ, Bataller R, Nanau RM, Voiculescu M, Opris M, Shen H, Tillman B, Li J, Liu H, Thomes PG, Ganesan M, Malnick S.

Exp Mol Pathol. 2014 Dec;97(3):492-510. doi: 10.1016/j.yexmp.2014.09.005. Epub 2014 Sep 11. Review.

5.

Therapy for alcoholic liver disease.

Jaurigue MM, Cappell MS.

World J Gastroenterol. 2014 Mar 7;20(9):2143-58. doi: 10.3748/wjg.v20.i9.2143. Review.

6.

Comparison of hepatocellular carcinoma patients with alcoholic liver disease and nonalcoholic steatohepatitis.

Hashimoto E, Taniai M, Kaneda H, Tokushige K, Hasegawa K, Okuda H, Shiratori K, Takasaki K.

Alcohol Clin Exp Res. 2004 Aug;28(8 Suppl Proceedings):164S-168S.

PMID:
15318106
7.

[Established therapies and new therapeutic strategies in alcoholic liver disease].

Seitz HK, Mueller S.

Z Gastroenterol. 2017 Mar;55(3):291-303. doi: 10.1055/s-0042-119454. Epub 2016 Dec 6. Review. German.

PMID:
27923259
8.

Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Kim MS, Ong M, Qu X.

World J Gastroenterol. 2016 Jan 7;22(1):8-23. doi: 10.3748/wjg.v22.i1.8. Review.

9.

Ultrasonography for diagnosis of alcoholic cirrhosis in people with alcoholic liver disease.

Pavlov CS, Casazza G, Semenistaia M, Nikolova D, Tsochatzis E, Liusina E, Ivashkin VT, Gluud C.

Cochrane Database Syst Rev. 2016 Mar 2;3:CD011602. doi: 10.1002/14651858.CD011602.pub2. Review.

10.

Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.

Marot A, Henrion J, Knebel JF, Moreno C, Deltenre P.

PLoS One. 2017 Oct 27;12(10):e0186715. doi: 10.1371/journal.pone.0186715. eCollection 2017.

11.

Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.

Lackner C, Spindelboeck W, Haybaeck J, Douschan P, Rainer F, Terracciano L, Haas J, Berghold A, Bataller R, Stauber RE.

J Hepatol. 2017 Mar;66(3):610-618. doi: 10.1016/j.jhep.2016.11.011. Epub 2016 Nov 25.

PMID:
27894795
12.

Diagnosis of alcoholic liver disease.

Torruellas C, French SW, Medici V.

World J Gastroenterol. 2014 Sep 7;20(33):11684-99. doi: 10.3748/wjg.v20.i33.11684. Review.

13.
14.

Alcoholic liver disease.

Bruha R, Dvorak K, Petrtyl J.

World J Hepatol. 2012 Mar 27;4(3):81-90. doi: 10.4254/wjh.v4.i3.81.

15.

Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.

Stickel F, Datz C, Hampe J, Bataller R.

Gut Liver. 2017 Mar 15;11(2):173-188. doi: 10.5009/gnl16477. Review. Erratum in: Gut Liver. 2017 May 15;11(3):447.

16.

Acetaldehyde adducts in alcoholic liver disease.

Setshedi M, Wands JR, Monte SM.

Oxid Med Cell Longev. 2010 May-Jun;3(3):178-85. doi: 10.4161/oxim.3.3.12288. Review.

17.

Diagnosis and Management of Alcoholic Liver Disease.

Dugum M, McCullough A.

J Clin Transl Hepatol. 2015 Jun 28;3(2):109-16. doi: 10.14218/JCTH.2015.00008. Epub 2015 Jun 15. Review.

18.

Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.

Kojima H, Sakurai S, Uemura M, Takekawa T, Morimoto H, Tamagawa Y, Fukui H.

Alcohol Clin Exp Res. 2005 Dec;29(12 Suppl):259S-63S.

PMID:
16385233
19.

Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.

Wu WB, Chen YY, Zhu B, Peng XM, Zhang SW, Zhou ML.

Biochimie. 2015 Aug;115:86-92. doi: 10.1016/j.biochi.2015.05.014. Epub 2015 May 27. Erratum in: Biochimie. 2015 Dec;119:204.

PMID:
26025474
20.

Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.

Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, Charlton M.

Gastroenterology. 2017 Apr;152(5):1090-1099.e1. doi: 10.1053/j.gastro.2017.01.003. Epub 2017 Jan 11.

Supplemental Content

Support Center